Physician profile

Eric Berkowitz

Vascular & Interventional Radiology · Bethpage, NY

NPI 1508805805

$1,062.24

in general payments reported to CMS, 2019-2025

11 companies · none reported in 2025

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$121.76

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Abbott Laboratories $202.49 2020-2021
Merz North America, INC. $196.56 2022
Vyne Pharmaceuticals INC. $150.69 2020-2021
Cook Medical LLC $119.99 2021
Bard Peripheral Vascular, INC. $108.91 2020
Dermavant Sciences, INC. $98.61 2023-2024 Vtama
Medtronic Vascular, INC. $72.99 2019
Galderma Laboratories, L.P. $42.83 2020-2024
Medtronic, INC. $30.38 2022
Biotronik INC. $21.56 2022
Epi Health, LLC $17.23 2020

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Eric Berkowitz

$1,062.24

in general payments reported 2019-2025

Years
2019-2024
Top company
Abbott Laboratories

https://glasscript.com/doctor/249791/eric-berkowitz

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.